Rani Therapeutics Holdings Inc Cl A (RANI)

$1.82 -0.27 (-12.92%)
Market Cap 150.21M
Revenue (ttm) 1.03M
Net Income (ttm) -30.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,914.56%
Debt to Equity Ratio -3.91
Volume 12,384,300
Avg Vol 18,057,402
Day's Range N/A - N/A
Shares Out 71.87M
Stochastic %K 40%
Beta -0.02
Analysts Strong Sell
Price Target $9.00

Company Profile

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 457 3700
Address:
2051 Ringwood Avenue, San Jose, United States
MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 7:41 AM
Enter: $RANI Calls Strike Price: $2 Expiry Date: NOV 21 2025 Buy in Price: $0.35 - $0.35 Sell Price: $0.61 Profit : +73% (Turn every $1 into $1.73) Want Profitable Real-Time Options Alerts? šŸ‘‰ https://moneygroup.us/
0 Ā· Reply
P2SR
P2SR Oct. 25 at 1:08 AM
$BYND $SCNX $GSIT $RANI $NERV
0 Ā· Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 11:26 PM
Enter: $RANI NOV 21 2025 $2 CALLS Buy in Price: $0.30 - $0.35 Take Profit: $0.42 Stop Bleeding: $0.26 ROI Potential: 39% https://moneygroup.us/
0 Ā· Reply
tradeXLNC
tradeXLNC Oct. 24 at 11:15 PM
Insane week ā€“ some top names that hit our scanner and trended were $CIFR $CLSK $RANI $BYND $GSIT + many more. Rest up and have a great weekend everyone, see you guys on Monday for more tradingšŸ”„šŸ”„
0 Ā· Reply
wavw
wavw Oct. 24 at 10:45 PM
$RANI oversold
0 Ā· Reply
harrysinghw
harrysinghw Oct. 24 at 8:38 PM
$RANI and officially out of it. Bye
3 Ā· Reply
LowFloatScanner_
LowFloatScanner_ Oct. 24 at 8:36 PM
What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. only 700k float Are they pumping up ticker CMCT for 300% today!? Looks like all eyes are moving to CMCT now.. Watching: $BYND $RANI $SCNX $MSAI Adding
0 Ā· Reply
Msnlrainey
Msnlrainey Oct. 24 at 8:31 PM
$RANI my only red one today!
1 Ā· Reply
MB_1
MB_1 Oct. 24 at 8:15 PM
$RANI Alright, lets run some numbers. At 1.8$ RANI is basically trading at its cash value which is around 60-70$ million cash with 35-40 million shares equaling to around 1.7-2$ a share. That means the marketā€™s pricing in ZERO value for the RaniPill tech, ZERO for the BILLION(!) dollar Chugai deal, and ZERO for its pipeline. Itā€™s essentially assuming total failure. At these prices you are basically buying the company and getting ALL OF ITS SCIENCE FOR FREE. Anyone with a common sense will see why this is so bullish.
0 Ā· Reply
WycklyTrader
WycklyTrader Oct. 24 at 7:40 PM
$CGEM QNCX potential base breakout with upcoming FDA catalysts. DCB momentum watch: $PMI $RANI $VTYX $ARCT ...
0 Ā· Reply
Latest News on RANI
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

Oct 23, 2025, 4:05 PM EDT - 1 day ago

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Oct 23, 2025, 4:01 PM EDT - 1 day ago

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Rani Therapeutics: Initiating At Buy On Promising RaniPill Advancement With Chugai

Oct 20, 2025, 2:20 PM EDT - 4 days ago

Rani Therapeutics: Initiating At Buy On Promising RaniPill Advancement With Chugai

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

Oct 20, 2025, 9:42 AM EDT - 4 days ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC CRMD RAPT

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma

Oct 17, 2025, 7:48 AM EDT - 8 days ago

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Oct 17, 2025, 7:31 AM EDT - 8 days ago

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

Oct 17, 2025, 7:30 AM EDT - 8 days ago

Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update

Aug 7, 2025, 4:05 PM EDT - 2 months ago

Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering

Jul 15, 2025, 9:00 AM EDT - 3 months ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery

Jul 14, 2025, 5:00 AM EDT - 3 months ago

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery

Rani Therapeutics Announces Research Agreement with Chugai

May 19, 2025, 8:00 AM EDT - 5 months ago

Rani Therapeutics Announces Research Agreement with Chugai

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

May 13, 2025, 4:05 PM EDT - 5 months ago

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 7:15 PM EDT - 7 months ago

Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call Transcript

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Mar 31, 2025, 4:05 PM EDT - 7 months ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPillĀ® Capsule, to Subcutaneously Administered PG-102

Mar 26, 2025, 4:05 PM EDT - 7 months ago

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPillĀ® Capsule, to Subcutaneously Administered PG-102

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Mar 25, 2025, 6:00 PM EDT - 7 months ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants

Oct 15, 2024, 8:30 AM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 8, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit

Rani Therapeutics to Participate in September Investor Conferences

Sep 3, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in September Investor Conferences

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update

Rani Therapeutics to Participate in August Investor Conferences

Jul 29, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Participate in August Investor Conferences

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering

Jul 22, 2024, 8:30 AM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

Jun 24, 2024, 7:00 AM EDT - 1 year ago

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

Rani Therapeutics to Participate in May Investor Conferences

May 14, 2024, 8:00 AM EDT - 1 year ago

Rani Therapeutics to Participate in May Investor Conferences

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPillĀ® Capsule at Digestive Disease Week 2024

May 9, 2024, 8:00 AM EDT - 1 year ago

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPillĀ® Capsule at Digestive Disease Week 2024

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

May 6, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 7:05 PM EDT - 1 year ago

Rani Therapeutics Holdings, Inc. (RANI) Q4 2023 Earnings Call Transcript

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Mar 20, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Mar 15, 2024, 4:05 PM EDT - 1 year ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

Dec 14, 2023, 8:00 AM EST - 2 years ago

Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Nov 8, 2023, 4:05 PM EST - 2 years ago

Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update

Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study

Oct 19, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study

Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research

Oct 12, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research

Rani Therapeutics: Excellent Technology But Major Risks Ahead

Sep 19, 2023, 6:36 AM EDT - 2 years ago

Rani Therapeutics: Excellent Technology But Major Risks Ahead

Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPillĀ® Containing Ustekinumab Biosimilar, CT-P43)

Sep 18, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPillĀ® Containing Ustekinumab Biosimilar, CT-P43)

Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies

Sep 7, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies

Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update

Aug 11, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update

Rani Therapeutics' Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference

Jun 21, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics' Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

Jun 8, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

Jun 5, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

Rani Therapeutics to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics to Present at the Jefferies Healthcare Conference

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

May 31, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference

Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

May 24, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update

May 10, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update

Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage

May 5, 2023, 5:33 PM EDT - 2 years ago

Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage

Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

Apr 11, 2023, 8:00 AM EDT - 2 years ago

Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference

Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Call Transcript

Mar 22, 2023, 6:43 PM EDT - 2 years ago

Rani Therapeutics Holdings, Inc. (RANI) Q4 2022 Earnings Call Transcript

Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update

Mar 22, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update

Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates

Mar 16, 2023, 4:05 PM EDT - 2 years ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates

MoneyGroupLLC
MoneyGroupLLC Oct. 25 at 7:41 AM
Enter: $RANI Calls Strike Price: $2 Expiry Date: NOV 21 2025 Buy in Price: $0.35 - $0.35 Sell Price: $0.61 Profit : +73% (Turn every $1 into $1.73) Want Profitable Real-Time Options Alerts? šŸ‘‰ https://moneygroup.us/
0 Ā· Reply
P2SR
P2SR Oct. 25 at 1:08 AM
$BYND $SCNX $GSIT $RANI $NERV
0 Ā· Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 11:26 PM
Enter: $RANI NOV 21 2025 $2 CALLS Buy in Price: $0.30 - $0.35 Take Profit: $0.42 Stop Bleeding: $0.26 ROI Potential: 39% https://moneygroup.us/
0 Ā· Reply
tradeXLNC
tradeXLNC Oct. 24 at 11:15 PM
Insane week ā€“ some top names that hit our scanner and trended were $CIFR $CLSK $RANI $BYND $GSIT + many more. Rest up and have a great weekend everyone, see you guys on Monday for more tradingšŸ”„šŸ”„
0 Ā· Reply
wavw
wavw Oct. 24 at 10:45 PM
$RANI oversold
0 Ā· Reply
harrysinghw
harrysinghw Oct. 24 at 8:38 PM
$RANI and officially out of it. Bye
3 Ā· Reply
LowFloatScanner_
LowFloatScanner_ Oct. 24 at 8:36 PM
What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. only 700k float Are they pumping up ticker CMCT for 300% today!? Looks like all eyes are moving to CMCT now.. Watching: $BYND $RANI $SCNX $MSAI Adding
0 Ā· Reply
Msnlrainey
Msnlrainey Oct. 24 at 8:31 PM
$RANI my only red one today!
1 Ā· Reply
MB_1
MB_1 Oct. 24 at 8:15 PM
$RANI Alright, lets run some numbers. At 1.8$ RANI is basically trading at its cash value which is around 60-70$ million cash with 35-40 million shares equaling to around 1.7-2$ a share. That means the marketā€™s pricing in ZERO value for the RaniPill tech, ZERO for the BILLION(!) dollar Chugai deal, and ZERO for its pipeline. Itā€™s essentially assuming total failure. At these prices you are basically buying the company and getting ALL OF ITS SCIENCE FOR FREE. Anyone with a common sense will see why this is so bullish.
0 Ā· Reply
WycklyTrader
WycklyTrader Oct. 24 at 7:40 PM
$CGEM QNCX potential base breakout with upcoming FDA catalysts. DCB momentum watch: $PMI $RANI $VTYX $ARCT ...
0 Ā· Reply
harrysinghw
harrysinghw Oct. 24 at 7:22 PM
$RANI my stop loss hit thanks
0 Ā· Reply
HeilHiden
HeilHiden Oct. 24 at 7:19 PM
$RANI THANK YOU
0 Ā· Reply
Superxyz
Superxyz Oct. 24 at 6:59 PM
$RANI on RANI was founded on 2012 Feb 31st, and went public on 2021 July and the highest price of that month was $12.25 . on November , 2021, the all time high price was $36.271. Today , 2025 October 24, the price is $1.82. so , what has changed between November 2021 where the all time high price was $36.271 and today , 2025, October , 24 the same stock the price is $1.82 ? which is over valued and which was under valued??
0 Ā· Reply
harrysinghw
harrysinghw Oct. 24 at 6:53 PM
$RANI stop loss set at 1.78. Sorry guys this going down to 1 next week
1 Ā· Reply
Juststartingout14
Juststartingout14 Oct. 24 at 6:34 PM
$RANI canā€™t wait until this starts turning. And all shirts have to buy back! It will be epic!
1 Ā· Reply
10xSniper
10xSniper Oct. 24 at 6:17 PM
$AREB $BENF $NERV $RANI $WGRX
0 Ā· Reply
StockSenseiTrendTraders
StockSenseiTrendTraders Oct. 24 at 6:12 PM
šŸ”„ Top 5 Winning Alerts This Week! šŸ”„ 1ļøāƒ£ $BENF šŸš€ +124.29% šŸ”¹ Entry Alert: 0.70 šŸ”¹ Ran To: 1.57 2ļøāƒ£ $WGRX šŸš€ +97.3% šŸ”¹ Entry Alert: 0.74 šŸ”¹ Ran To: 1.46 3ļøāƒ£ $AREB šŸš€ +95.05% šŸ”¹ Entry Alert: 1.82 šŸ”¹ Ran To: 3.55 4ļøāƒ£ $NERV šŸš€ +86.53% šŸ”¹ Entry Alert: 6.68 šŸ”¹ Ran To: 12.46 5ļøāƒ£ $RANI šŸš€ +32.39% šŸ”¹ Entry Alert: 2.13 šŸ”¹ Ran To: 2.82 šŸ“Š 2025 Performance Highlights āœ… Wins: 1,230 āŒ Losses: 94 šŸš€ Gain Potential: +63,366% āœØ Avg Gain/Winning Alert: 51.52%
0 Ā· Reply
llchen1204
llchen1204 Oct. 24 at 6:08 PM
$RANI double bottomed at 1.8. reversal now. buy the bottom and become rich
2 Ā· Reply
deno2546
deno2546 Oct. 24 at 5:36 PM
$RANI hold your horse. It's dropping to 1.3ish before it does its thing stay calm bull
1 Ā· Reply
TheePharoah
TheePharoah Oct. 24 at 5:27 PM
$RANI RANI stinks !.
0 Ā· Reply
HeilHiden
HeilHiden Oct. 24 at 4:43 PM
$RANI what should we expect to see on the next quarterly report?
1 Ā· Reply
jaj89
jaj89 Oct. 24 at 4:16 PM
$RANI this is surely an arse hole stock?
0 Ā· Reply